New data for Smith+Nephew’s CARTIHEAL◊ AGILI-C◊ Cartilage Repair Implant demonstrates superior pain relief and functional gains at 5 years (1)

robot
Abstract generation in progress

Smith+Nephew announced new 5-year data from a multicenter, randomized controlled trial for its CARTIHEAL AGILI-C Cartilage Repair Implant, published in the American Journal of Sports Medicine. The data indicates superior pain relief and functional gains compared to standard surgical care, with comparable outcomes for patients with and without osteoarthritis. This implant addresses a critical treatment gap for patients whose cartilage damage is too extensive for standard repair but not severe enough for joint replacement.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin